270 related articles for article (PubMed ID: 22129639)
1. The role of fructose-enriched diets in mechanisms of nonalcoholic fatty liver disease.
Nomura K; Yamanouchi T
J Nutr Biochem; 2012 Mar; 23(3):203-8. PubMed ID: 22129639
[TBL] [Abstract][Full Text] [Related]
2. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
3. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.
Rolo AP; Teodoro JS; Palmeira CM
Free Radic Biol Med; 2012 Jan; 52(1):59-69. PubMed ID: 22064361
[TBL] [Abstract][Full Text] [Related]
4. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
5. Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy L; Lê KA
Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):554-60. PubMed ID: 22795319
[TBL] [Abstract][Full Text] [Related]
6. [NASH -- nonalcoholic steatohepatitis].
Blechacz B; Stremmel W
Z Gastroenterol; 2003 Jan; 41(1):77-90. PubMed ID: 12541180
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic steatohepatitis and the metabolic syndrome.
Jiang J; Torok N
Metab Syndr Relat Disord; 2008 Mar; 6(1):1-7. PubMed ID: 18370830
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
Cave M; Deaciuc I; Mendez C; Song Z; Joshi-Barve S; Barve S; McClain C
J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
[TBL] [Abstract][Full Text] [Related]
9. [Patomechanisms of hepatic steatosis].
Fülöp P; Paragh G
Orv Hetil; 2010 Feb; 151(9):323-9. PubMed ID: 20159747
[TBL] [Abstract][Full Text] [Related]
10. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
11. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
Tessari P; Coracina A; Cosma A; Tiengo A
Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease.
Smith BW; Adams LA
Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
Rahimi RS; Landaverde C
Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
[TBL] [Abstract][Full Text] [Related]
14. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.
Fujita K; Nozaki Y; Yoneda M; Wada K; Takahashi H; Kirikoshi H; Inamori M; Saito S; Iwasaki T; Terauchi Y; Maeyama S; Nakajima A
Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S18-24. PubMed ID: 18986378
[TBL] [Abstract][Full Text] [Related]
16. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis.
Nocito A; Dahm F; Jochum W; Jang JH; Georgiev P; Bader M; Renner EL; Clavien PA
Gastroenterology; 2007 Aug; 133(2):608-18. PubMed ID: 17681180
[TBL] [Abstract][Full Text] [Related]
17. Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.
Yki-Järvinen H
Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):709-14. PubMed ID: 20842026
[TBL] [Abstract][Full Text] [Related]
18. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
19. From the metabolic syndrome to NAFLD or vice versa?
Vanni E; Bugianesi E; Kotronen A; De Minicis S; Yki-Järvinen H; Svegliati-Baroni G
Dig Liver Dis; 2010 May; 42(5):320-30. PubMed ID: 20207596
[TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.
Wanless IR; Shiota K
Semin Liver Dis; 2004 Feb; 24(1):99-106. PubMed ID: 15085490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
